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To verify the value of eschars for the diagnosis of scrub
typhus and to characterize genotypes of Orientia tsutsuga-
mushi in patients, we examined eschars and blood speci-
mens of 7 patients from Shandong Province, People’s
Republic of China, for O. tsutsugamushi by polymerase
chain reaction targeting the Sta56 gene. All 7 eschars and
acute-phase blood samples were positive, while no specif-
ic DNA amplicons were obtained from the 7 convalescent-
phase blood samples collected after antimicrobial drug
therapy. The findings indicate that patients’ eschars can be
used for detection and genetic characterization of O. tsut-
sugamushi during the convalescent phase.
S
crub typhus, a widely endemic disease in Asian Pacific
regions, is caused by Orientia tsutsugamushi, a gram-
negative obligate intracellular bacterium in the family
Rickettsiaceae. When the rickettsia is transmitted to a
human through the bite of an infected mite, it begins to
multiply at the bite site, and a characteristic skin lesion
known as an eschar is formed. The pathogen then spreads
systemically by the hematogenous and lymphogenous
routes. Various clinical manifestations develop, including
fever, rash, and lymphadenopathy (1).
Before 1986, scrub typhus was only found in southern
China (south of the Yangtze River) primarily in the sum-
mer. O. tsutsugamushi, which causes “summer-type scrub
typhus,” is highly virulent and usually transmitted by the
Leptotrombidium deliense mite. In 1986, scrub typhus was
first reported in Mengyin County, Shandong Province,
north of the Yangtze River. This newly recognized
“autumn-winter type scrub typhus” is caused by a less vir-
ulent strain of O. tsutsugamushi and transmitted by the L.
scutellare mite (1,2). Since then, cases of autumn-winter
scrub typhus have been increasingly reported in many
northern areas of China; eschars developed in 82%–91%
of those infected (1,2).
Traditionally, the diagnosis of scrub typhus mainly
relied on serologic tests. The disease could be retrospec-
tively diagnosed in cases of seroconversion or a >4-fold
rise in antibody titers between acute-phase and convales-
cent-phase serum specimens. The requirement of double
serum specimens has limited its usage for diagnosis.
Recently a polymerase chain reaction (PCR) assay was
developed for detecting O. tsutsugamushi Sta56 gene in
blood samples or isolates from patients (3–8). However,
the test often gave a false-negative result because hemo-
globin and other components in blood may inhibit PCR
amplification (3,4,9). The commonly seen eschars in scrub
typhus patients were suggested as alternative specimens
for diagnosis (9). The objectives of this study were to ver-
ify the value of eschars for the diagnosis of scrub typhus
by PCR assay and to characterize the genotype of O. tsut-
sugamushi during the convalescent phase.
Materials and Methods
Sample Collection
Seven scrub typhus patients reported at Feixian County
(116°11′–118°18′E, 35°01′–35°33′N), Shandong Province,
China, in September, October, and November of
2003–2004 were included in the study. The identification
(ID) codes, age, sex, the locations of eschars, and other
clinical characteristics on admission were documented
(Table). The typical eschars of 2 patients (03PE1 and
04PE5) are shown in the Figure. After informed consent
was obtained, 5 mL acute-phase blood was collected from
each patient before treatment. Chloramphenicol was then
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days. Fever resolved for all 7 patients within 2 days of
treatment. Eschar specimens and 5-mLconvalescent-phase
blood sample from each patient were collected at the time
that the eschar spontaneously desquamated (6–15 days
after treatment). Serum specimens were separated by cen-
trifugation at 2,500× g for 10 min. All specimens from
eschars, serum, and residual blood clots were kept at
−70°C until use.
Detection of IgG Antibodies against O. tsutsugamushi
An indirect immunofluorescent antibody assay (IFA)
was performed as described previously (10), by using
mixed Gilliam, Karp, and Kato strains of O. tsutsugamushi
as diagnostic antigen. Scrub typhus was diagnosed in the
case of seroconversion or a >4-fold rise in IgG antibody
titers between acute-phase and convalescent-phase sera.
DNA Extraction
Complete eschars (30–60 mg in weight) or 0.3 mL
blood clot was homogenized with TE (10 mmol/L Tris Cl
[pH 8.0] and 1 mmol/L EDTA) buffer and centrifuged at
3,000× g for 5 min; the supernatant was discarded. For the
blood clot, the precipitate was resuspended and washed
with TE buffer 3 times to eliminate the residual inhibitors
in blood. Then 400 µL lysis buffer (10 mmol/L Tris [pH
8.0], 0.1 mol/L EDTA, 0.5% sodium dodecyl sulfate), 10
µL proteinase K (20 mg/mL; Promega Corp., Madison,
WI, USA), and 2 µL lysozyme (4 mg/mL; DingGuo
Biotech. Co. Ltd, Beijing, People’s Republic of China)
were added, and incubated at 50°C for 6 h. DNA was
extracted with phenol/chloroform/isoamylalcohol (25:
24:1) and precipitated in ethanol. Finally, the DNA was
washed with 75% ethanol and dissolved in 20 µL distilled
water.
PCR Amplification
PCR amplification of the Sta56 gene was performed by
using species-specific primers, Pr1 (5′-tac att agc tgc agg
tat gac-3′) and Pr2 (5′-AAT TCT TCA ACC AAG CGA
TCC-3′) (3,4,10). The amplifications were performed in a
volume of 50 µL with a Perkin-Elmer model 2400 thermal
cycler (Perkin-Elmer, Norwalk, CT, USA). The amplifica-
tion program consisted of 1 cycle for 5 min at 94°C, 35
cycles of denaturation at 94°C for 30 s, annealing at 56°C
for 1 min, and extension at 72°C for 1 min. This process
was followed by a final extension at 72°C for 5 min. The
amplification products then underwent electrophoresis in a
2% agarose gel containing ethidium bromide and visual-
ized under UV light.
The acute- and convalescent-phase blood samples were
processed and run through the PCR instrument at the same
time as the eschar specimens. DNA from reference strains
of Gilliam, Karp, and Kato was used as positive controls,
and distilled water was used as a negative control in each
amplification. To avoid contamination, DNA extraction,
reagent setup, PCR, and electrophoresis were performed in
separate rooms.
Sequence Analysis
The purified PCR amplicons of all the positive samples
were sequenced by Shanghai Invitrogen Biotechnology
Co. Ltd (Shanghai, People’s Republic of China). The
sequences were compared with all available reported O.
tsutsugamushi Sta56 gene sequences in GenBank by using
BLAST (Basic Local Alignment Search Tool) program
(available from www.ncbi.nlm.nih.gov/BLAST). The
GenBank accession numbers of sequences obtained from
the 7 patients in this study are DQ188085, DQ188086,
DQ188087, DQ188088, DQ188089, DQ188090, and
DQ188091, respectively.
Results
Seroconversion or a >4-fold rise in titers of IgG anti-
body to O. tsutsugamushi was observed in all 7 patients
(Table), thus confirming the diagnosis of scrub typhus.
Seven eschars and 7 acute-phase blood samples from the
patients were positive by PCR targeting the Sta56 gene,
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antimicrobial drug treatment were all PCR-negative.
The 317-bp partial sequence of the O. tsutsugamushi
Sta56 gene amplified from each eschar was identical to
that of its corresponding acute-phase blood sample. The
sequences from the 7 patients differed from each other by
1 or 2 bp; two sequences were identical. The nucleotide
sequences were 95.6%–97.8% homologous with the corre-
sponding parts of Kawasaki strain Sta56 gene deposited in
GenBank (accession no. M63383), while the sequence
homologies with other strains such as Karp, Kato, Kuroki,
Shimokoshi, and Je-cheon were all <75.87%.
Discussion
Previous studies used spleen tissues of infected mam-
mals or acute-phase blood from patients to detect O. tsut-
sugamushi by PCR (3,4). However, PCR amplification of
O. tsutsugamushi DNA from blood often lacks sensitivity
because some hemoglobin, iron porphyrin, and other fac-
tors may inhibit the PCR, although obtaining and process-
ing the blood that avoids the inhibitors is possible (3,4,9).
Ono et al. previously found O. tsutsugamushi DNA (iden-
tified as Kawasaki type) in only 1 patient’s eschar before
antimicrobial drug treatment but not in the acute-phase
blood sample (9). In the present study, 7 scrub typhus
patients were examined, and O. tsutsugamushi DNA was
successfully detected in their spontaneously desquamated
eschars and acute-phase blood samples. These findings
further proved that eschars could be used as an alternative,
easily acquired, and sensitive sample for the diagnosis of
O. tsutsugamushi infection, particularly when persons are
reluctant to provide a blood sample because of cultural or
other reasons.
We described a new simple confirmatory diagnostic
assay in which eschars are used as an alternative to sero-
logic tests such as IFA, which usually requires double
blood samples from acute and convalescent phases. In
addition, from the successful and efficient detection of the
O. tsutsugamushi DNA in naturally desquamated eschars,
we can infer the presence of the agent in eschars before
beginning antimicrobial drug therapy. If eschars had been
sampled during the acute phase by punch biopsy, this
method could be used for the early diagnosis of scrub
typhus.
A previous study carried out in Thailand detected O.
tsutsugamushi DNA in convalescent-phase blood of
patients after a single dose of doxycycline (10). However,
in the present study, O. tsutsugamushi DNA was not per-
sistent in the convalescent-phase blood of patients after
4–5 days of chloramphenicol treatment. Whether a lack of
PCR sensitivity or difference in the treatment regimens
explains the apparent lack of O. tsutsugamushi DNAin the
convalescent-phase blood samples is not known. A possi-
ble reason is that the patients in the present study were
infected with the less virulent strain of O. tsutsugamushi
(11), which may only persist in blood for a short period
after antimicrobial drug treatment. Our previous study
indicated that to isolate O. tsutsugamushi from patients
with autumn-winter scrub typhus, cyclophosphamide (0.25
mg/g of body weight) had to be injected into the experi-
mental mice after injection of patients’ blood to suppress
immunity (11).
Sequence analysis of partial Sta56 gene clarified that
the genotypes of O. tsutsugamushi in the scrub typhus
patients from Shandong Province, China, were more close-
ly related to Kawasaki type, which is less virulent than
other genotypes and only caused a mild syndrome (1). The
finding has applications for physicians to treat patients and
prescribe medicine.
Dr Liu is a professor of epidemiology at the Beijing Institute
of Microbiology and Epidemiology. His research interests focus
on vectorborne infectious diseases and highly pathogenic avian
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Figure. The locations of typical eschars in 2 representative
patients with scrub typhus. A) An eschar on the neck of a patient
(03PE1). B) An eschar on the waist of a patient (04PE5).
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